These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7028047)

  • 1. [Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)].
    Adam W; Peil HG; Savopoulos C; Vanderbeke O
    Arzneimittelforschung; 1981; 31(8A):1360-5. PubMed ID: 7028047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative double-blind study on ciclopiroxolamine cream and placebo cream in dermatophytoses (author's transl)].
    Fredriksson T; Savopoulos C
    Arzneimittelforschung; 1981; 31(8A):1376-8. PubMed ID: 7028050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-European open clinical studies on the efficacy and tolerance of ciclopiroxolamine in dermatomycoses (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1381-5. PubMed ID: 7028052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Open clinical trial in dermal mycoses of a 1% ciclopiroxolamine solution in polyethylene glycol 400 carried out in FR Germany/Study with shortened therapy (author's transl)].
    Torres J; Savopoulos C; Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1373-6. PubMed ID: 7028049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selected double-blind comparative studies on the efficacy and tolerance of ciclopiroxolamine solution and cream].
    Beyer M
    Arzneimittelforschung; 1981; 31(8A):1378-81. PubMed ID: 7028051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Open clinical study on the efficacy and tolerance of ciclopiroxolamine in vulvovaginal candidosis (author's transl)].
    Peil HG
    Arzneimittelforschung; 1981; 31(8A):1366-8. PubMed ID: 7028048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the local efficacy of ciclopiroxolamine in onychomycoses (author's transl)].
    Qadripur SA; Horn G; Höhler T
    Arzneimittelforschung; 1981; 31(8A):1369-72. PubMed ID: 6457608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liberation of ciclopiroxolamine from dermatological preparations (author's transl)].
    Petri W
    Arzneimittelforschung; 1981; 31(8A):1332-7. PubMed ID: 7197540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical study of cyclopyroxolamine versus clotrimazole in the treatment of mycotic vulvovaginitis].
    Giannoni M; Pollastro M; Jacobellis M
    Minerva Med; 1990; 81(7-8):555-9. PubMed ID: 2199853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological laboratory studies with ciclopiroxolamine (author's transl)].
    Dittmar W; Grau W; Raether W; Schrinner E; Wagner WH
    Arzneimittelforschung; 1981; 31(8A):1317-22. PubMed ID: 7197538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind evaluation of fenticonazole cream 2% and clotrimazole cream 1% in dermatomycoses.
    Finzi A; Fioroni A; Monici Preti P; Mounari M
    Mykosen; 1986 Jan; 29(1):41-4. PubMed ID: 3515169
    [No Abstract]   [Full Text] [Related]  

  • 12. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.
    Jue SG; Dawson GW; Brogden RN
    Drugs; 1985 Apr; 29(4):330-41. PubMed ID: 3158508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D; Reichenberger M
    Mykosen; 1980 Dec; 23(12):657-68. PubMed ID: 7012610
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris.
    Bogaert H; Cordero C; Ollague W; Savin RC; Shalita AR; Zaias N
    J Int Med Res; 1986; 14(4):210-6. PubMed ID: 3530834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H; Luszpinski P
    Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the mechanism of antifungal action of ciclopiroxolamine/Inhibition of transmembrane transport of amino acid, K+ and phosphate in Candida albicans cells (author's transl)].
    Iwata K; Yamaguchi H
    Arzneimittelforschung; 1981; 31(8A):1323-7. PubMed ID: 7028046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group.
    Alomar A; Videla S; Delgadillo J; Gich I; Izquierdo I; Forn J
    Dermatology; 1995; 190(4):295-300. PubMed ID: 7655109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Penetration and antifungal activity of ciclopiroxolamine in hornified tissue (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1353-9. PubMed ID: 7197542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of bifonazole and ciclopiroxolamine: in vitro, animal, and clinical studies.
    Hänel H; Abrams B; Dittmar W; Ehlers G
    Mycoses; 1988 Dec; 31(12):632-40. PubMed ID: 3068545
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of seborrheic eczema with an antifungal agent with an antiphlogistic effect].
    Hänel H; Smith-Kurtz E; Pastowsky S
    Mycoses; 1991; 34 Suppl 1():91-3. PubMed ID: 1840158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.